Joel Isaacson & Co’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Joel Isaacson & Co’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-375	Closed	-$4.59K	–	323
2023 Q2	$4.59K	Hold	375	–	–	﹤0.01%	321
2023 Q1	$5.37K	Hold	375	–	–	﹤0.01%	326
2022 Q4	$5.62K	Sell	375 -20	-5%	-$576	﹤0.01%	321
2022 Q3	$15K	Hold	395	–	–	﹤0.01%	296
2022 Q2	$30K	Hold	395	–	–	﹤0.01%	293
2022 Q1	$43K	Sell	395 -80	-17%	-$4.81K	﹤0.01%	305
2021 Q4	$33K	Hold	475	–	–	﹤0.01%	306
2021 Q3	$69K	Hold	475	–	–	0.01%	304
2021 Q2	$291K	Buy	+475	New	+$310K	0.02%	236

Other funds holding MDVL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Joel Isaacson & Co's MDVL Position: Q3 2023 in Review

Joel Isaacson & Co sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2023, closing a stake of 375 shares — an estimated $4.59K sold.

Joel Isaacson & Co first reported a position in MDVL in Q2 2021 and held it in 9 quarters. The position peaked at $291K in Q2 2021. 19 funds tracked by Wall St. Rank hold MDVL as of Q3 2023.

Joel Isaacson & Co reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Joel Isaacson & Co sold 375 MedAvail Holdings, Inc. Common Stock shares in Q3 2023, an estimated $4.59K.
Joel Isaacson & Co first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
Joel Isaacson & Co's MedAvail Holdings, Inc. Common Stock position peaked at $291K in Q2 2021.
19 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2023.

Based on Joel Isaacson & Co's 13F filing for Q3 2023, filed 24 Oct 2023.